Top Markets
Coin of the day
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
주식 순위 #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
주가
$1.81
마지막 동기화: 2026-08-21
시가총액
$77.00M
변동 (1일)
1.30%
변동 (1년)
-23.63%
국가
US
거래 Annovis Bio, Inc. (ANVS)

카테고리

Annovis Bio, Inc. (ANVS)의 주가 이력
최고 종가: $1.82 (2026-08-01 기준)

최저 종가: $7.71 (2020-01-01 기준)
Annovis Bio, Inc.의 주가 이력 (2020 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -38.81%
2025 -26.28%
2024 -55.51%
2023 0.70%
2022 -41.39%
2021 233.32%
2020 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH